Unpublished in Chile: UdeC launches course on medicinal use of sativa cannabis in people
The University of Concepción began its first course on Themedicinal use of sativa cannabis and its derivatives in people.
The initiative is named "Phytocannabinoids in medicine and endocannabinoid system:Mechanisms of action, clinical use and associated risks", which has50 participantsand held at the Santiago headquarters of the study house, located inMarchant Pereira Street No10Providence.
Fernando Sepúlveda, assistant professor in the Department of Biochemistry and Molecular Biology at the Faculty of Biological Sciences of the University of Concepción and academic coordinator of the activity, explained that - for the most part-doctors and other health professionalswho are part of the course.
"It is a training course that seeks to provide skills to health professionals in matters that have to do with the use of cannabis and its derivatives, both witha therapeutic look, as well as with the look of risks"Sepúlveda noted, noting that they decided on Santiago in order to encompass a greater number of stakeholders.
In turn, he indicated that the course seeks to deliver information that is useful to health care providers, specifically those who work with people and who are the ones who are"face"day by day to patients.
As far as the use of cannabis is concerned medicinally, Sepúlveda stated that "societywas ahead of the medical environment, the academy and the university", adding that what awaits you now as a study house is "respond and try to guide, to help. To do what universities do, which is basically generating knowledge and bonding with society."
Benefits and risks
Asked about the effectiveness of this plant to treat medical conditions, Sepúlveda stated that "there are diseases that are likely to be cured with cannabinoids, however, they are diseases that are now defined as rare", further stating that there are other common conditions, but thathas not been proventhat can be cured by cannabis.
He also stated that there are several situations that are potentially risky, noting that "any acute organic dysfunction, such as a heart beating badly or a liver functioning poorly, are all conditions in which I do not recommend the use of cannabinoids ", advising that the symptoms be normalized first and then proceed to the indicated treatment.
In the same vein, the professor appealed not to apply cannabis derivatives in terms of"complicated mental illnesses, such as schizophrenia, schizoid disorders, deep depression and bipolar disorders".
"What we are looking for iscontextualize the good part, but also contextualize the risky part," fernando Sepúlveda said.
In short, the methodology will consist ofhour-long lessonclasss, in charge of expert professionals of the various topics to be dealt with.
In relation to the schedules, this Thursday's day will run until 18:00 hours, while the second - and final - will take place tomorrow from 09:15 until 19:00 hours, this in the direction already indicated.
